TY  - JOUR

T1  - Study EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC)—Trial in progress.

JO  - Journal of Clinical Oncology

UR  - http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps582

PY  - 2023/02/20

AU  - Kamat AM

AU  - Steinberg GD

AU  - Inman BA

AU  - Kates MR

AU  - Uchio EM

AU  - Porten SP

AU  - Roupret M

AU  - Redorta J

AU  - Catto JWF

AU  - Kulkarni GS

AU  - Powles T et al

ED  - 

DO  - DOI: 10.1200/jco.2023.41.6_suppl.tps582

PB  - American Society of Clinical Oncology (ASCO)

VL  - 41

IS  - 6_suppl

SP  - TPS582

EP  - TPS582

Y2  - 2024/12/29

ER  -